Klor-con/ef Generic Name & Formulations
Potassium (as bicarbonate) 25mEq; effervescent tabs; fruit flavor.
M10—90, 100, 1000; M15—100, 1000; M20—90, 100, 500, 1000; Klor-Con 8, 10—100, 500; Pwd—30, 100; Klor-Con/EF—30, 100
Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.
Klor-con/ef Dosage and Administration
Take with meals and fluids. Swallow tabs whole; may break Klor-Con M tabs in half, or mix in 4oz water. Effervescent tabs, pwd: dissolve in beverage. Prophylaxis: 20mEq daily. Treatment: 40–100mEq daily in divided doses; max 20mEq/dose.
Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility.
Klor-con/ef Boxed Warnings
Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.
Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.
Klor-con/ef Adverse Reactions
Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation.
Klor-con/ef Clinical Trials
Klor-con/ef Patient Counseling